SAPHNELO Co-pay Savings Program
OpenVerified·Mar 20, 2026
- Covers
- financial assistance
- Enrollment cycle
- rolling
Eligibility
Eligible patients must be adults with moderate to severe systemic lupus erythematosus (SLE) currently receiving other lupus medicines. The co-pay savings program is specifically for US consumers with commercial or private insurance.
Status source
SIGN UP FOR SAPHNELO SUPPORTS
Rare-disease support beyond financial help
This grant covers a rare condition. For specialists, clinical trials, and patient communities, our sister site UniteRare.org has in-depth pages: